Close Menu
June 16, 2020
Sponsored by
Illumina

Environmental DNA (eDNA) and Metabarcoding: A Transformational Approach to Biodiversity Monitoring

GenomeWebinar

Associate Professor,
Department of Integrative Biology & Centre for Biodiversity Genomics, University of Guelph

All living organisms shed DNA into their environment, and these traces of DNA can now be profiled using next-generation sequencing. Thanks to a colossal effort around the world to sequence the molecular markers (e.g. DNA barcodes) of hundreds of thousands of eukaryotic species, we now have databases that allow us to match eDNA to its sources. By using the massive capacity of high-throughput sequencers, we can now survey the presence and dynamics of shifts in biodiversity in different environments and monitor it over time. 

Existing methods for environmental surveys are costly and time consuming, often relying on invasive or destructive sampling methods, and specialist expertise from taxonomists to correctly identify species. Metabarcoding promises to be a complementary alternative that will enable researchers, governments, and industry to gain more comprehensive insights into changes in biodiversity, and make more informed choices around conservation, environmental impact assessment, water quality monitoring, biosecurity, and more. 

This webinar will review recent research and validation experiments demonstrating the power of metabarcoding for a range of potential applications. 

Attendees of this webinar will learn about: 

  • Biodiversity markers and DNA barcoding
  • Metabarcoding and environmental DNA
  • Sample types and sampling regimes
  • Next-generation sequencing approaches for eDNA metabarcoding
  • Bioinformatics for taxonomic assignment and validation
  • Experimental design aspects from sample to data analysis and interpretation
  • Freshwater metabarcoding for water quality assessment
  • Soil metabarcoding for ecological surveys
  • Comprehensive biodiversity assessment in seawater using ultra-deep metabarcoding
Sponsored by

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.

Sep
24
Sponsored by
ArcherDX

NTRK fusions are oncogenic drivers in a variety of tumors.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
06
Sponsored by
10x Genomics

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease characterized by irreversible scarring of the distal lung, leading to respiratory failure. 

Oct
08
Sponsored by
Genecentric

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.